The first results of a clinical trial show the safety and therapeutic potential of transient repeated blood-brain-barrier disruption in Alzheimer’s patients.
The Strengthening American Cybersecurity Act, which President Biden has signed into law, requires hospitals to report cybersecurity incidents and ransomware payments. How will the new law impact medical device companies?